LIFR and thyroid cancer: LIFR-AS1 was also found to be significantly upregulated in thyroid cancer tissues and cell lines, and its silencing reduced the viability and inhibited the proliferation of human thyroid cancer cells by inducing G2/M cell cycle arrest, possibly through the suppression of cyclin B1 and CDK1.